Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hogy Medical CoHGYMF 57 3-Year ROIIC % is 24.95 as of Mar. 2025, which is 13% below its 10-year median of 28.61. GuruFocus rates HGYMF with a GF Score™ of 57/100 and a GF Value™ of $23.24. The stock has 10 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Hogy Medical Co ranks better than 73.99% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Hogy Medical Co's 3-Year ROIIC % for the quarter that ended in Mar. 2025 was 24.95%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Hogy Medical Co's 3-Year ROIIC % or its related term are showing as below:
HGYMF's 3-Year ROIIC % is ranked better than 73.99% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.62
vs HGYMF: 24.95
Hogy Medical Co (OTCPK:HGYMF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Hogy Medical Co 3-Year ROIIC % Related Terms
Hogy Medical Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Hogy Medical Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HGYMF vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Hogy Medical Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hogy Medical Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hogy Medical Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Hogy Medical Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Hogy Medical Co (HGYMF) has a 3-Year ROIIC % of 24.95 as of Mar. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Hogy Medical Co and its competitors. This is 13% below median its historical median of 28.61. According to the industry distribution chart, Hogy Medical Co ranks #207 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 26%.
Is Hogy Medical Co's 3-Year ROIIC % too high?
Hogy Medical Co's current 3-Year ROIIC % of 24.95 is 13% below median its 10-year median of 28.61. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Hogy Medical Co's value of 24.95 is 1440.1% above this industry median. Based on the distribution chart, Hogy Medical Co ranks #207 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hogy Medical Co has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hogy Medical Co ranks #207 out of 796 companies for 3-Year ROIIC %. This puts Hogy Medical Co in the upper half of its industry. The industry median 3-Year ROIIC % is 1.62. Hogy Medical Co's value of 24.95 is 1440.1% above this benchmark. While the company's 10-year median is 28.61 vs. the industry median of 1.62, Hogy Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hogy Medical Co's current 3-Year ROIIC % of 24.95 is 1440.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Hogy Medical Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hogy Medical Co's current 3-Year ROIIC % is 24.95, which is 13% below median its own 10-year median of 28.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Hogy Medical Co (HGYMF) has a current 3-Year ROIIC % of 24.95. The stock's GF Value™ is $23.24, compared to a current price of $34.99 — trading 50.6% above its estimated fair value. The current 3-Year ROIIC % is 24.95, which is 13% below median its 10-year median of 28.61 and 1440.1% above the Medical Devices & Instruments industry median of 1.62. Hogy Medical Co's overall GF Score™ is 57/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Hogy Medical Co (HGYMF), the current 3-Year ROIIC % is 24.95 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hogy Medical Co (HGYMF) Overvalued in 2026?
Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued.
The current stock price of $34.99 is trading 50.6% above its estimated GF Value™ of $23.24.
Key valuation signals for HGYMF:
3-Year ROIIC %: 24.95 (13% below median its 10-year median of 28.61)
GF Value™: $23.24 vs. price of $34.99 (50.6% above fair value)
Industry Position: 1440.1% above the Medical Devices & Instruments median (#207 of 796)
No single metric tells the full story. See the HGYMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
57GF Score
Get the complete analysis for HGYMF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HGYMF has been successfully added to your 
